Dark

Check out our API

INVO
INVO BioScience,INC Common Stock
stock NASDAQ

Inactive

Oct 21, 2024

0.8330USD-2.914%(-0.0250)125,261

Pre-market

0.00USD-100.000%(-0.86)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 19, 2022

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 Benzinga

08:21AM EST Maxim Group Initiates Coverage On INVO Bioscience with Buy Rating, Announces Price Target of $7 Benzinga

Dec 16, 2021

09:06AM EST INVO Bioscience Reports Deal With Ovoclinic In Spain To Expand INVOcell Commercialization, No Terms Disclosed Benzinga

09:01AM EST INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand PR Newswire

Dec 10, 2021

02:06PM EST INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor PR Newswire

02:06PM EST INVO Bioscience To Participate In Lytham Partners Winter 2021 Investor Conference Benzinga

Dec 1, 2021

09:14AM EST INVO Bioscience Obtains Regulatory Approval To Commercialize INVOcell In Thailand Benzinga

09:02AM EST INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In PR Newswire

Nov 15, 2021

06:34PM EST INVO Bioscience Q3 EPS $(0.24) Misses $(0.20) Estimate, Adj. EBITDA Loss $1.6M, Sales $218.87K Miss $330.00K Estimate Benzinga

04:06PM EST INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and PR Newswire

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 9, 2021

04:15PM EST INVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, PR Newswire

11:13AM EST INVO Bioscience Reports Regained Full US Commercialization Rights Benzinga

Nov 8, 2021

04:15PM EST INVO Bioscience Regains Full U.S. Commercialization Rights PR Newswire

Oct 20, 2021

09:03AM EDT INVO Bioscience Highlights 4 Poster Abstracts On INVOcell Presented At American Society For Reproductive Medicine Congress Benzinga

09:02AM EDT Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo PR Newswire

Oct 14, 2021

09:00AM EDT INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" PR Newswire

Oct 8, 2021

05:59AM EDT INVO Bioscience CEO Steve Shum Reported Purchase of 30,674 Shares @ Avg Price of $3.26/Share in Form 4 Filing on Thursday Benzinga

Oct 1, 2021

11:16AM EDT INVO Bioscience Earnings Perspective: Return On Capital Employed Benzinga

09:35AM EDT INVO Bioscience Announces $4M Registered Direct Offering, 1.2M Shares At $3.26/Share Benzinga

09:33AM EDT INVO Bioscience Announces $4.0 Mln Registered Direct Offering Priced At-The-Market RTTNews

09:30AM EDT INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced PR Newswire

Sep 9, 2021

08:01AM EDT INVO Bioscience Advances INVOcell(r) Commercialization Efforts With Acquisition PR Newswire

Sep 7, 2021

09:12AM EDT INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" PR Newswire

Sep 3, 2021

09:01AM EDT Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO PR Newswire

Aug 18, 2021

09:30AM EDT Roth Capital Maintains Buy on INVO Bioscience, Lowers Price Target to $5.25 Benzinga

Aug 16, 2021

04:30PM EDT INVO Bioscience Q2 Net Loss ~$1.8M, Adj. EBITDA Loss $1.3M, Sales $208.47K Miss $410.00K Estimate Benzinga

04:06PM EDT INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and PR Newswire

04:04AM EDT Earnings Scheduled For August 16, 2021 Benzinga

Aug 5, 2021

04:16PM EDT INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, PR Newswire

Aug 2, 2021

04:06PM EDT INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for PR Newswire

Jul 14, 2021

08:37AM EDT INVO Bioscience Appoints Barbara Levy As Senior VP, Global Clinical Integration RTTNews

Jun 30, 2021

09:33AM EDT INVO Bioscience Signs JV Agreement With Bloom Fertility To Open INVOcell Fertility Clinic In Atlanta RTTNews

09:31AM EDT INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an PR Newswire

09:31AM EDT INVO Bioscience Reports Joint Venture Deal With Bloom Fertility To Open An INVOcell Fertility Clinic In Atlanta Benzinga

Jun 15, 2021

09:12AM EDT INVO Bioscience Appoints Andrea Goren As CFO RTTNews

09:09AM EDT INVO Bioscience Names Andrea Goren CFO Benzinga

09:03AM EDT INVO Bioscience Appoints Andrea Goren as Chief Financial Officer PR Newswire

May 17, 2021

04:29PM EDT INVO Bioscience Q1 EPS $(0.25) Misses $(0.17) Estimate, Sales $684.52K Beat $590.00K Estimate Benzinga

04:05PM EDT INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and PR Newswire

04:10AM EDT Earnings Scheduled For May 17, 2021 Benzinga

May 11, 2021

04:15PM EDT INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May PR Newswire

May 10, 2021

08:31AM EDT INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global PR Newswire

Apr 26, 2021

04:05PM EDT INVO Bioscience Announces Appointment of Rebecca Messina to the Board of PR Newswire

Apr 22, 2021

11:03AM EDT INVO Bioscience Joins in Supporting RESOLVE: The National Infertility PR Newswire

Apr 19, 2021

09:06AM EDT INVO Bioscience Signs Partnership Agreement With Lyfe Medical To Establish INVOcell Clinic In Northern California Benzinga

09:02AM EDT INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish PR Newswire

Apr 13, 2021

09:35AM EDT INVO Bioscience Says Entered Into Partnership Agreement With Lyfe Medical Center; Says Will Receive 40% Of Net Income Received By Cruz Clinical For Performance Of Lab Services Under Partnership Agreement Benzinga

Apr 12, 2021

03:00PM EDT INVO Bioscience to Present at Tribe Public Event on April 13, 2021 PR Newswire

Apr 7, 2021

04:44PM EDT Invo Bioscience Files For Mixed Shelf Of Up To $35M Benzinga

Mar 30, 2021

04:15PM EDT INVO Biosciences Reports FY20 Sales $1.038M Down From $1.480M YoY Benzinga

04:10PM EDT INVO Bioscience Reports 2020 Financial Results PR Newswire

08:06AM EDT The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings Benzinga

04:04AM EDT Earnings Scheduled For March 30, 2021 Benzinga

Mar 29, 2021

09:01AM EDT INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor PR Newswire

Mar 26, 2021

09:02AM EDT INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results PR Newswire

Mar 15, 2021

08:43AM EDT INVO Biosciences Says Achieves Key Milestone, Signs Agreement To Open First Joint Venture INVOcell Clinic In U.S. Benzinga

08:31AM EDT INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint PR Newswire

Mar 11, 2021

09:01AM EST INVO Bioscience to Participate in the 33rd Annual Roth Conference PR Newswire

Mar 10, 2021

02:37PM EST Mid-Afternoon Market Update: Dow Surges 500 Points; US Budget Deficit Widens In February Benzinga

12:53PM EST Mid-Day Market Update: Dow Jumps Over 400 Points; Just Energy Shares Slide Benzinga

10:12AM EST Mid-Morning Market Update: Markets Open Higher; Campbell Soup Reports In-Line Earnings Benzinga

Mar 9, 2021

02:31PM EST Mid-Afternoon Market Update: Nasdaq Surges Over 500 Points; INVO Bioscience Shares Spike Higher Benzinga

12:19PM EST Mid-Day Market Update: Gold Rises Over 2%; ACADIA Pharmaceuticals Shares Plunge Benzinga

10:18AM EST Mid-Morning Market Update: Markets Open Higher; Dicks Sporting Goods Profit Beats Views Benzinga

09:15AM EST Invo Bioscience Stock Rallies After Amended Agreement Expands Company-Owned Clinics In US Benzinga

Mar 8, 2021

04:11PM EST INVO Bioscience Reports Amendment Under Its Exclusive US Commercialization Deal With Ferring Pharma, Allows For Increase In Number Of INVO-Owned Clinics Initially Allowable Under Deal, Removes Certain Geographical Restrictions Benzinga

04:10PM EST INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U.S. PR Newswire

Mar 1, 2021

09:08AM EST INVO Bioscience Obtains Regulatory Approval To Import INVOcell Into Mexico Benzinga

Jan 27, 2021

09:04AM EST INVO Bioscience Reports Advancement Of Commercialization Into European Fertility Market With Initial Orders Of INVOcell In Spain Benzinga

09:00AM EST INVO Bioscience Advances Commercialization into the European Fertility Market PR Newswire

Jan 15, 2021

08:31AM EST INVO Biosciences Expands Distribution Of INVOcell Into The Pakistan Infertility Market With Galaxy Pharma Benzinga

08:31AM EST INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility PR Newswire

Jan 7, 2021

09:01AM EST INVO Bioscience Management Letter to Shareholders PR Newswire

Nov 25, 2020

09:03AM EST INVO Bioscience, IdsMED Group Enter Distribution Deal For Malaysia RTTNews

09:02AM EST INVO Bioscience, idsMED Group Enter Distribution Agreement For Malaysia Benzinga

Nov 18, 2020

09:20AM EST INVO Bioscience Reports Formation Of Scientific Advisory Board Benzinga

09:02AM EST INVO Bioscience Forms Scientific Advisory Board with Leaders from Fertility PR Newswire

Nov 16, 2020

04:23PM EST INVO Bioscience Reports Q3 2020 Revenue Of $336,071, Net Loss Per Share Of $(0.36) Benzinga

04:20PM EST INVO Bioscience Reports Third Quarter 2020 Financial Results PR Newswire

Nov 13, 2020

05:59AM EST INVO Bioscience Priced 3.6M Share Public Offering @$3.20/Share; Co to List on the NASDAQ Capital Market Benzinga

Sep 30, 2020

09:15AM EDT INVO Bioscience Establishes Joint Venture to Operate Dedicated INVOcell PR Newswire

Sep 16, 2020

09:02AM EDT INVO Bioscience Announces Appointment of Barbara Ryan and Matthew Szot to the PR Newswire

Aug 13, 2020

04:15PM EDT INVO Bioscience Reports Second Quarter 2020 Financial Results PR Newswire

Aug 6, 2020

03:01PM EDT INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor PR Newswire

Jul 16, 2020

09:01AM EDT INVO Bioscience Receives Registration Approval for INVOcell in Turkey PR Newswire

Share